Patient Inclusion Criteria
All patients referred on HNC two-week-wait pathway between April 2020
and November 2020 were identified. All patients received an initial
telephone consultation and were followed up for six months. Patients who
received a new cancer diagnosis presenting with head and neck symptoms
at any point in this time were included in the study. Cases with cancers
that were incidentally diagnosed that were unrelated to the index
referral were excluded.